Quantcast

Wallcur to Provide Custom Practice Medication Packages for Elsevier’s SimChart®

June 26, 2014

PHILADELPHIA, June 26, 2014 /PRNewswire/ –

Wallcur’s Practi-Pack pre-built practice medication packages to complement

Elsevier’s simulated electronic health record learning tool for nursing students

Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical
and medical information products and services, today announced that Wallcur
[http://www.wallcur.com ], a provider of practice medications for clinical simulation and
health education, will make custom practice medications available to Elsevier’s SimChart
customers.

Nursing schools using Elsevier’s SimChart
[http://www.elsevieradvantage.com/article.jsp?pageid=10707 ], an educational electronic
health record (EHR), have access to multiple hands-on, evidence-based practice scenarios
that include preparing and administering of medications to patients. Through Elsevier’s
relationship with Wallcur, SimChart customers now have the ability to purchase
Practi-Packs, pre-built packages of medications that match up with 10 SimChart simulated
cases.

“Hands-on experience in a clinical setting is key for the advancement of health
science students, and practice with proper medication administration is an important part
of that education,” said John Danaher, President, Education, Elsevier. “Providing students
with realistic practice medications allows them to learn in a safe environment and
encourages preparedness for the clinical setting.”

The Practi-Packs have bar codes, enabling students to verify drug type and dosage when
administering the practice medication. The medication information also populates the EHR.
The simulation cases provide a realistic look and feel of a clinical setting and allow
students to treat different patient ailments with the Practi-Packs.

“Our mission at Wallcur is to provide products that simulate clinical learning in a
safe, non-clinical environment,” said Wendy LaGrange, Director of Sales & Marketing,
Wallcur. “By partnering with Elsevier, we’re able to make true-to-life medications
available to health science students as they prepare for the challenges of tomorrow’s
healthcare system.”

A sample simulation case includes a patient with myocardial infarction who is
experiencing hypertension and chest pain. After assessing the simulated patient’s
symptoms, the student will use the pre-packaged Practi-Packs to properly care for the
patient. Each Practi-Pack will have either two or four sets of the needed medications so
students can run through the scenario several times to encourage an increased level of
comfort with the medication administration and scenario results.

For more information, go to http://www.elsevieradvantage.com.

About Wallcur

For over 40 years, Wallcur [http://www.wallcur.com ] has been the leading innovator
and provider of educational training and simulation products for nursing, medical
assistance, pharmaceutical, EMS/paramedic, medical corps and other allied health programs
throughout the world. Our Practi-Products(TM) are designed to provide safe, accurate and
realistic clinical simulation practices guaranteed to increase student readiness, as well
as cut down on medication and administration errors. Our Practi(TM) brand guarantees the
highest quality, true-to-life realistic designs to create a safe and authentic practice
that is easily integrated into any new or existing curriculum, with the best customer
service and availability in the industry.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the
performance of science, health, and technology professionals, empowering them to make
better decisions, deliver better care, and sometimes make groundbreaking discoveries that
advance the boundaries of knowledge and human progress. Elsevier provides web-based,
digital solutions – among them ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], Elsevier Research Intelligence
[http://www.elsevier.com/online-tools/research-intelligence ] and ClinicalKey
[https://www.clinicalkey.com ] – and publishes nearly 2,200 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and over 25,000 book titles,
including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading provider of professional information solutions in the Science, Medical,
Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed
Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange),
RUK and ENL (New York Stock Exchange).

        Media contact
        Christopher Capot
        Director, Corporate Relations
        Elsevier
        +1-212-633-3164
        c.capot@elsevier.com

SOURCE Elsevier


Source: PR Newswire



comments powered by Disqus